|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1987-9-28
|
|
pubmed:abstractText |
1 Isoxicam was found to inhibit monocyte and neutrophil cell chemotaxis at therapeutic concentrations. 2 The effect was observed after in vitro incubation of normal cells and in vivo in patients with rheumatoid arthritis. 3 Compared to other NSAIDs studied in our laboratory, isoxicam was shown to have a broader spectrum of inhibitory action on the cells involved in the chronic inflammation associated with rheumatoid arthritis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0306-5251
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22 Suppl 2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
117S-119S
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:3620270-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:3620270-Arthritis, Rheumatoid,
pubmed-meshheading:3620270-Chemotaxis, Leukocyte,
pubmed-meshheading:3620270-Female,
pubmed-meshheading:3620270-Humans,
pubmed-meshheading:3620270-Male,
pubmed-meshheading:3620270-Monocytes,
pubmed-meshheading:3620270-Neutrophils,
pubmed-meshheading:3620270-Piroxicam
|
|
pubmed:year |
1986
|
|
pubmed:articleTitle |
The effect of isoxicam on neutrophil and monocyte function.
|
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|
